Ticker Scorecard - EYPT Basics Company: EyePoint Pharmaceuticals, Inc. Common Stock IPO Date: February 1, 2005 Sector: Healthcare Industry: Pharma Market Cap: $489.36M Activated in VL: True Average Daily Range Avg Daily Range: $0.26 | 3.76% Avg Daily Range (30 D): $0.30 | 3.83% Avg Daily Range (90 D): $0.34 | 3.79% Institutional Daily Volume Avg Daily Volume: .32M Avg Daily Volume (30 D): .57M Avg Daily Volume (90 D): .68M Trade Size Avg Trade Size (Sh.): 79 Avg Trade Size (Sh.) (30 D): 73 Avg Trade Size (Sh.) (90 D): 80 Institutional Trades Total Inst.Trades: 585 Avg Inst. Trade: $1.68M Avg Inst. Trade (30 D): $1.58M Avg Inst. Trade (90 D): $1.36M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.75M Avg Closing Trade (30 D): $1.76M Avg Closing Trade (90 D): $1.21M Avg Closing Volume: 125.99K     News Jan 30, 2025 @ 12:00 PM EyePoint to Present at Guggenheim SMID Cap Biotech... Source: N/A Jan 16, 2025 @ 12:00 PM EyePoint Pharmaceuticals Reports Inducement Grants... Source: N/A Oct 30, 2024 @ 1:47 AM EyePoint Pharmaceuticals Announces Pricing of Upsi... Source: N/A Oct 28, 2024 @ 9:14 PM EyePoint Pharmaceuticals Announces Proposed Public... Source: Globe Newswire Aug 27, 2024 @ 11:00 AM EyePoint Pharmaceuticals Announces Participation a... Source: N/A Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.54 $-.58 $-.55 Diluted EPS $-.54 $-.58 $-.55 Revenue $ 10.52M $ 9.48M $ 11.68M Gross Profit $ 9.79M $ 8.08M $ 10.93M Net Income / Loss $ -29.36M $ -30.83M $ -29.28M Operating Income / Loss $ -32.75M $ -34.55M $ -33.32M Cost of Revenue $ .74M $ 1.4M $ .76M Net Cash Flow $ -10.94M $ -180.24M $ -10.25M PE Ratio     Splits Dec 09, 2020:   10:1 Jun 11, 2008:   4:1